Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-24-000817)

Filing Details

Accession Number:: 0001415889-24-000817
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-01-08 17:50:12
Reporting Period:: 2024-01-05

Accepted Time:: 2024-01-08 17:50:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1673772	Rapt Therapeutics Inc.	RAPT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1635616	G. Dirk Brockstedt	C/O Rapt Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA 94080	Chief Scientific Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-01-05	898	$22.78	27,820	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares were sold solely to pay taxes due upon vesting of the Restricted Stock Units granted on January 30, 2020 for 8,000 shares.
Includes 1,646 shares and two shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on April 28, 2023 and October 31, 2023, respectively.